对于妇科恶性瘤,化疗的高成本
Nobutaka Takahashi1, Toshiyuki Seki2, Keita Sasaki3
1Department of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan.
Japanese journal of clinical oncology
|July 18, 2024
概括
高成本的癌症药物,如PARP抑制剂和贝瓦齐祖马布,对于卵巢和宫癌是常见的,大大增加了医疗费用. 这些先进的治疗方法比传统的治疗方法贵10-20倍.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 临床研究 临床研究
背景情况:
- 通过向药物和免疫治疗,妇科癌症的预后得到了改善.
- 这些先进的治疗方法在医疗保健中带来了重大的财务挑战.
研究的目的:
- 评估高成本药物治疗方案在妇科癌症护理中的流行程度.
- 了解日本先进疗法的经济影响.
主要方法:
- 一个问卷调查是由JCOG健康经济委员会进行的.
- 该调查针对2021年7月至2022年6月的JCOG附属设施.
- 评估了用于卵巢和宫癌的高成本治疗方案的流行程度.
主要成果:
- 59.1%的卵巢癌患者接受了使用多 (腺二酸盐-糖) 聚合酶 (PARP) 抑制剂 (>500,000日元/月) 的治疗方案.
- 13.0%的卵巢癌患者接受了贝瓦西祖马布治疗方案 (>200,000日元/月).
- 48.4%的宫癌患者接受了贝瓦西祖马布治疗方案 (>20万日元/月),成本是传统治疗的10倍.
结论:
- 超过70%的卵巢癌患者和约50%的宫癌患者使用了昂贵的治疗方案.
- 这些先进的治疗方法比传统疗法成本高10-20倍.
- 这些发现支持未来关于成本效益的健康经济学研究.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
191
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
191
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
244
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
244
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


